Thursday, August 30, 2012

Additional Details Concerning Issue of Shares to Johnson & Johnson Development Corporation as Part of the Daratumumab Agreement

...continued

URL: http://www.investorpoint.com/news/IPONEWS1/53896258/

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)